Editorial: Recent advances in progestin-primed ovarian stimulation

Editorial: Recent advances in progestin-primed ovarian stimulation

Dades bibliogràfiques
Autor principal:	Qiuju Chen
Format:	Article
Idioma:	English
Publicat:	Frontiers Media S.A. 2022-11-01
Col·lecció:	Frontiers in Endocrinology
Matèries:	In vitro fertilization controlled ovarian stimulation progestin-primed ovarian stimulation (PPOS) poor ovarian response (POR) GnRH analogue
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1004352/full

Ítems similars

Progestin-Primed Ovarian Stimulation versus GnRH Antagonist Protocol for Ovarian Stimulation in IVF: A Prospective Pilot Study
per: Tien K. Le, et al.
Publicat: (2024-03-01)

Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis
per: Le Duc Thang, et al.
Publicat: (2024-04-01)

Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma
per: Ai-Min Yang, et al.
Publicat: (2022-04-01)

Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF
per: Angel Hsin-Yu Pai, et al.
Publicat: (2023-08-01)

Micronized natural progesterone (Seidigestan®) vs GnRH antagonists for preventing the LH surge during controlled ovarian stimulation (PRO_NAT study): study protocol of a randomized clinical trial
per: M. Martínez-Moya, et al.
Publicat: (2024-03-01)

Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval
per: Tzu-Ching Kao, et al.
Publicat: (2023-01-01)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
per: Qiuju Chen, et al.
Publicat: (2019-11-01)

Progestin-primed ovarian stimulation outcomes in in-vitro fertilization (IVF) – A systematic review of the literature
per: Vyacheslav Notanovich Lokshin, et al.
Publicat: (2024-12-01)

Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study
per: Ahui Liu, et al.
Publicat: (2022-12-01)

Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis
per: Mingze Du, et al.
Publicat: (2021-09-01)

Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response
per: Junwei Zhang, et al.
Publicat: (2021-09-01)

Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome
per: Hongjuan Ye, et al.
Publicat: (2018-05-01)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
per: Erkan Kalafat, et al.
Publicat: (2022-05-01)

Validating the Use of Corifollitropin Alfa in Progestin-Primed Ovarian Stimulation Protocol on Normal and High Responders by Comparing with Conventional Antagonist Protocol: A Retrospective Study
per: Chen-Yu Huang, et al.
Publicat: (2020-06-01)

Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations
per: Ruiqiong Zhou, et al.
Publicat: (2023-04-01)

Nomogram to predict FSH starting dose in poor ovarian response women in progestin primed ovarian stimulation protocol
per: Shuxie Wu, et al.
Publicat: (2023-04-01)

Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment
per: Yali Liu, et al.
Publicat: (2022-08-01)

Effect of progestin-primed ovarian stimulation protocol in infertile women with basal follicle-stimulating hormone levels ≥15 IU/L: A retrospective analysis
per: Lu Fang, et al.
Publicat: (2020-01-01)

Clinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation
per: Yu Li, et al.
Publicat: (2012-01-01)

Neonatal outcomes and congenital malformations in children born after progestin-primed ovarian stimulation protocol
per: Danjun Li, et al.
Publicat: (2022-11-01)

Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score–matched cohort study
per: Mingze Du, et al.
Publicat: (2023-06-01)

The construction of machine learning-based predictive models for high-quality embryo formation in poor ovarian response patients with progestin-primed ovarian stimulation
per: Yu-Heng Xiao, et al.
Publicat: (2024-07-01)

Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review and meta-analysis
per: Liu Yang, et al.
Publicat: (2023-09-01)

A novel GnRH-antagonist protocol by switching to medroxyprogesterone when patients being at risk of ovarian hyperstimulation syndrome during ovarian stimulation
per: Ting-Chi Huang, et al.
Publicat: (2020-11-01)

OVARIAN STIMULATION FOR IVF-ET PROCEDURE
per: Robert Medved, et al.
Publicat: (2002-03-01)

The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis
per: Guangyao Lin, et al.
Publicat: (2023-08-01)

New Twists in Ovarian Stimulation and Their Practical Implications
per: Paul Pirtea, et al.
Publicat: (2019-09-01)

Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study
per: Huang J, et al.
Publicat: (2019-07-01)

Progestin-Primed Ovarian Stimulation Protocol for Patients in Assisted Reproductive Technology: A Meta-Analysis of Randomized Controlled Trials
per: Shaogen Guan, et al.
Publicat: (2021-08-01)

Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
per: Jialyu Huang, et al.
Publicat: (2019-05-01)

The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study
per: Ying Zhang, et al.
Publicat: (2023-12-01)

Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study
per: Shaodi Zhang, et al.
Publicat: (2021-06-01)

Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study
per: Qian Peng, et al.
Publicat: (2019-11-01)

GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization
per: Robab Davar, et al.
Publicat: (2010-09-01)

Optimal Ovulation Trigger–Oocyte Pickup Interval in Progestin-Primed Ovarian Stimulation Protocol: A Retrospective Study Using Propensity Score Matching
per: Xi Shen, et al.
Publicat: (2019-10-01)

Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial
per: Yun Wang, et al.
Publicat: (2018-08-01)

Editorial: GnRH agonist triggering of final oocyte maturation: Improving safety without compromising success
per: Johnny Awwad, et al.
Publicat: (2023-03-01)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
per: Mu Lv, et al.
Publicat: (2022-10-01)

Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
per: Shan Liu, et al.
Publicat: (2021-07-01)

Progestin-primed ovarian stimulation with letrozole using different doses of medroxyprogesterone acetate per day: a retrospective cohort study
per: Hai-long Li, et al.
Publicat: (2024-07-01)